# Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position

> **NCT04661124** · — · COMPLETED · sponsor: **Heidelberg Engineering GmbH** · enrollment: 88 (actual)

## Conditions studied

- Retinal Disease
- Healthy Eyes

## Interventions

- **DEVICE:** SPECTRALIS
- **DEVICE:** SPECTRALIS with Flex Module

## Key facts

- **NCT ID:** NCT04661124
- **Lead sponsor:** Heidelberg Engineering GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-10
- **Primary completion:** 2021-09-17
- **Final completion:** 2024-04-22
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661124, "Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04661124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*